| http://www.w3.org/ns/prov#value | - Curiously, 7q22 deletions are particularly common in patients who develop leukemia as a second malignant neoplasm after chemotherapy with DNA alkylating drugs.1 It is tempting to speculate that loss of Mll5 might sensitize hematopoietic progenitor populations to DNA damaging agents.
|
